According to Alexandria Real Estate Equities 's latest financial reports the company's total assets are $37.69 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $36.77 B | 3.51% |
2022-12-31 | $35.52 B | 17.55% |
2021-12-31 | $30.21 B | 32.38% |
2020-12-31 | $22.82 B | 24.13% |
2019-12-31 | $18.39 B | 27.14% |
2018-12-31 | $14.46 B | 19.51% |
2017-12-31 | $12.10 B | 16.89% |
2016-12-31 | $10.35 B | 16.6% |
2015-12-31 | $8.88 B | 9.16% |
2014-12-31 | $8.13 B | 8.05% |
2013-12-31 | $7.52 B | 5.31% |
2012-12-31 | $7.15 B | 8.76% |
2011-12-31 | $6.57 B | 11.32% |
2010-12-31 | $5.90 B | 8.22% |
2009-12-31 | $5.45 B | 6.34% |
2008-12-31 | $5.13 B | 10.56% |
2007-12-31 | $4.64 B | 28.32% |
2006-12-31 | $3.61 B | 53.12% |
2005-12-31 | $2.36 B | 26.18% |
2004-12-31 | $1.87 B | 47.13% |
2003-12-31 | $1.27 B | 9.78% |
2002-12-31 | $1.15 B | 20.49% |
2001-12-31 | $0.96 B |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Pfizer PFE | $226.50 B | 500.81% | ๐บ๐ธ USA |
Eli Lilly LLY | $63.94 B | 69.62% | ๐บ๐ธ USA |
Amgen AMGN | $97.15 B | 157.71% | ๐บ๐ธ USA |
Gilead Sciences GILD | $62.12 B | 64.79% | ๐บ๐ธ USA |
Illumina ILMN | $10.11 B | -73.18% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $99.03 B | 162.69% | ๐บ๐ธ USA |
Alnylam Pharmaceuticals
ALNY | $3.82 B | -89.86% | ๐บ๐ธ USA |